Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[knuts4oe]

The ball remains in Jonnie Williams' court as we not so patiently await an announcement of the FDA Phase 1 results and the plan for the FDA Phase 2 MYMD-1 vs Hashimoto's Thyroiditis bout. Perhaps this will come with the reopening of the MYMD Pharmaceuticals website.

The folks at MYMD are probably getting all their ducks in a row in the expectation that MYMD-1 will be the winner in the Phase 2 results. It is my hope that MYMD Pharma would then select an international pharmaceutical company for a worldwide exclusive license to develop isomyosmine molecules for all other Autoimmune System Diseases. Such an agreement would include upfront license fees and a reasonable royalty agreement on eventual sales.

We continue to live in hope especially since MYMD Pharma has said they are working on molecules for a broad range of conditions including cardiovascular disease, neurological disease, and aging.